Scarica l'app Stockscreener
1.92
0.00%
0.00
Precedente Chiudi:
$1.92
Aprire:
$1.96
Volume 24 ore:
361.33K
Relative Volume:
0.59
Capitalizzazione di mercato:
$71.77M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-14.67%
1M Prestazione:
+0.52%
6M Prestazione:
-22.58%
1 anno Prestazione:
-44.67%
Intervallo 1D:
$1.82
$1.965
Intervallo di 1 settimana:
$1.82
$2.32
Portata 52W:
$1.23
$4.92
Metagenomi Inc Stock (MGX) Company Profile
Nome
Metagenomi Inc
Settore
Industria
Telefono
(510) 871-4880
Indirizzo
5959 HORTON STREET, EMERYVILLE
Confronta MGX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MGX
Metagenomi Inc
|
1.92 | 78.50M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Metagenomi Inc Stock (MGX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-07 | Iniziato | H.C. Wainwright | Buy |
| 2024-05-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-03-05 | Iniziato | BMO Capital Markets | Outperform |
| 2024-03-05 | Iniziato | Chardan Capital Markets | Buy |
| 2024-03-05 | Iniziato | JP Morgan | Overweight |
| 2024-03-05 | Iniziato | Jefferies | Buy |
| 2024-03-05 | Iniziato | TD Cowen | Outperform |
| 2024-03-05 | Iniziato | Wells Fargo | Overweight |
Mostra tutto
Metagenomi Inc Borsa (MGX) Ultime notizie
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 25, 2024 in Metagenomi LawsuitMGX - ACCESS Newswire
Metagenomi, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before November 25, 2024 to Discuss Your RightsMGX - ACCESS Newswire
Metagenomi Sells The Gene-Editing Dream—But Risk Looms Large - Finimize
How does Metagenomi Inc. compare to its industry peersTremendous return rates - Jammu Links News
When is Metagenomi Inc. stock expected to show significant growthBreakneck growth rates - Jammu Links News
Published on: 2025-08-04 03:23:40 - Jammu Links News
Should I hold or sell Metagenomi Inc. stock in 2025Outstanding stock performance - Jammu Links News
Metagenomi Inc. Stock Analysis and ForecastGet real-time alerts on top-performing stocks - Jammu Links News
Is it the right time to buy Metagenomi Inc. stockOutstanding capital returns - Jammu Links News
How many analysts rate Metagenomi Inc. as a “Buy”High-performance investment picks - Jammu Links News
What catalysts could drive Metagenomi Inc. stock higher in 2025Double-digit growth - Jammu Links News
What analysts say about Metagenomi Inc. stockHigh-return market picks - jammulinksnews.com
How volatile is Metagenomi Inc. stock compared to the marketMarket-crushing stock picks - Jammu Links News
What is Metagenomi Inc. company’s growth strategyAchieve rapid capital gains with smart investing - Jammu Links News
Is Metagenomi Inc. stock overvalued or undervaluedRapidly growing investment returns - Jammu Links News
How strong is Metagenomi Inc. company’s balance sheetPowerful market insights - Jammu Links News
How does Metagenomi Inc. generate profit in a changing economyGet professional advice for portfolio optimization - Jammu Links News
Is Metagenomi Inc. a growth stock or a value stockExceptional trading results - Jammu Links News
Discover People are buying the wrong stock thinking it's part of OpenAI's Stargate Project - Quartz
What are analysts’ price targets for Metagenomi Inc. in the next 12 monthsInvest in high-yield stocks with confidence - Jammu Links News
Analyzing Metagenomi Inc. with risk reward ratio chartsFree Investment Playbook for Growing Markets - Newser
What is the risk reward ratio of investing in Metagenomi Inc. stockSmart Portfolio Data Feed For 2025 - Jammu Links News
Metagenomi Inc. stock trendline breakdownMomentum Entry Alerts with Risk Control - Newser
What makes Metagenomi Inc. stock price move sharplyCommunity Entry Consensus Trade Ideas Shared - metal.it
How Metagenomi Inc. stock performs during market volatilitySector-Wise Stock Strength Trend Analysis - Newser
Will Metagenomi Inc. stock benefit from AI tech trendsRisk Adjusted Technical Entry Plan Gains Followers - metal.it
Price momentum metrics for Metagenomi Inc. explainedProfit Target Stock Opportunity Monitor Activated - metal.it
Metagenomi (MGX) Presents Latest in Gene Editing Technologies - Insider Monkey
Metagenomi Advances Gene Editing Technologies with Presentations at ASGCT Meeting - AInvest
Is Metagenomi Inc. Stock a Good Fit for Conservative InvestorsWeekly Market Direction and Sector Summary - Newser
Metagenomi Inc. Stock Support and Resistance Levels You Should KnowFree Real Market Momentum Signal Generator - Newser
Is Metagenomi Inc. building a consolidation baseAsset Growth Pattern and Return Summary - Newser
Will Metagenomi Inc. stock benefit from AI tech trends Fundamental + Technical Combined Watchlist - Newser
Why is Metagenomi Inc. stock attracting strong analyst attentionUnlock powerful trading signals for profits - Jammu Links News
Metagenomi Inc Azioni (MGX) Dati Finanziari
Non sono disponibili dati finanziari per Metagenomi Inc (MGX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.24%
3.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):